Here’s why UiPath is sliding

Traders Union
All News
Financial News
Uipath slides 5.02% today

Highlights

Federated Hermes Inc. reduced its UiPath stake by 7.7% in Q3, selling 620,599 shares and retaining 7,427,722 shares.
The reduction coincided with elevated trading volumes, reflecting increased institutional activity and influencing market sentiment.
PATH trades at $12.59, below key moving averages, with strong selling pressure and support expected near the $12.50 level.

Institutional stake reduction and high volumes drive sentiment shift

Federated Hermes Inc. reduced its stake in UiPath by selling 620,599 shares in the third quarter, representing a 7.7% decrease and leaving the firm with 7,427,722 shares. This significant change in shareholder position was accompanied by notably high trading volumes, pointing to increased institutional activity. Elevated trading activity was the main factor influencing market sentiment.

Anton Kharitonov, expert at Traders Union, notes that UiPath trades persistently below all major moving averages, confirming sustained bearish pressure. He highlights the reduction in Federated Hermes Inc.'s stake and institutional selling as a driver of negative sentiment. Technical signals remain weak, with oversold conditions showing exhaustion but no sign of a reversal. Trading near today's lows illustrates ongoing vulnerability and a failure to attract dip buyers. Kharitonov warns, "Persistent institutional exits and lackluster momentum paint a risky short-term outlook for PATH."

Viktoras Karapetjanc, expert at Traders Union, sees elevated institutional activity as a positive sign for long-term positioning. He believes recent selling by Federated Hermes may signal rebalancing rather than fundamental weakness. Karapetjanc notes that oversold oscillators create technical setups for a reversal. He highlights that the bullish structure remains attainable if the price regains key resistance. Karapetjanc says, "This volatility offers opportunity — further growth is possible if momentum shifts above the $12.88 level."

Parshwa Turakhiya, analyst, observes intense short-term selling as PATH trades near daily lows and below all major averages. He sees technical exhaustion in indicators such as RSI, CCI, and Stoch RSI, which could attract speculative bounce traders. However, Turakhiya cautions that sellers dominate intraday momentum and advises focusing on defined risk levels. He adds, "If price manages a technical bounce from $12.67, short-term setups could materialize, but bulls must stay vigilant."

Persistent downside momentum despite oversold technical signals

Momentum indicators suggest weak price strength. The daily MACD is firmly negative and in sell territory, while ADX at 16.95 signals a lack of strong trend. Multiple oscillators including RSI (34.78), CCI, and Stoch RSI are oversold, confirming downside exhaustion, but daily BBP and most momentum signals indicate sellers still dominate intraday action. The Awesome Oscillator is neutral and offers little directional bias. PATH is down 5.02% so far today, with almost no gap at the open. The price is moving near today's low, indicating high intraday volatility and continued downward pressure after the open. Despite some signs of short-term oversold conditions, there is a clear divergence as momentum and oscillators suggest potential for a technical bounce, yet bears keep control of the session.

Last time, analysts noted that UiPath Inc. remained under persistent bearish pressure, with its share price trading below all key moving averages and technical indicators such as RSI and MACD confirming negative momentum amid rising institutional selling. Resistance was seen near $13.50, while further downside risk prevailed as the stock hovered just above key support levels and trend signals remained weak.

Source of Data: PATH Price Analysis by TU

The analysis is based on a proprietary model combining technical, on-chain, and expert data. Not investment advice. See methodology

This material may contain third-party opinions, none of the data and information on this webpage constitutes investment advice according to our Disclaimer. While we adhere to strict Editorial Integrity, this post may contain references to products from our partners.